Mupirocin Infectopharm (Mupirocin)

Mupirocin is a topical antibacterial indicated for skin conditions caused by susceptible bacteria.

• Impetigo: eradicates the causative Staphylococcus aureus or Streptococcus pyogenes and promotes lesion healing.
• Infected eczema: reduces bacterial colonisation and limits secondary infection flare‑ups.
• Minor cuts, abrasions and burns: prevents or treats superficial bacterial infection to support wound recovery.
• Surgical site prophylaxis (small superficial wounds): provides local antibacterial protection to reduce postoperative infection risk.

• Mupirocin inhibits bacterial isoleucyl‑tRNA synthetase, an enzyme essential for protein synthesis. By blocking the attachment of isoleucine to its tRNA, the drug prevents the formation of functional bacterial proteins, leading to halted bacterial growth and eventual cell death at the site of application.

Mupirocin is generally well tolerated when applied to intact skin, but local reactions may occur.

Common Side Effects

• Burning sensation at the application site
• Itching or pruritus
• Redness or erythema
• Dryness or flaking of the skin
• Mild irritation or stinging
• Local swelling

Serious or Rare Side Effects

• Allergic contact dermatitis
• Severe skin necrosis
• Anaphylactic reaction (rare)
• Systemic absorption leading to neutropenia (very rare)
• Extensive rash or urticaria
• Significant swelling or blistering of the treated area

Before using Mupirocin, consider the following safety measures.

• Assess for known hypersensitivity: avoid if patient has a documented allergy to mupirocin or other topical antibiotics.
• Avoid use on large, broken skin areas: limit application to small, localized lesions as recommended.
• Do not apply to eyes, ears, or mucous membranes: the formulation is intended for external skin only.
• Limit duration of therapy: follow prescriber instructions and discontinue if infection does not improve within the advised period.
• Store at room temperature: keep in the original container, protect from moisture and direct heat.

Mupirocin has limited systemic absorption, yet certain co‑applications may affect safety or efficacy.

Major Interactions (Avoid)

• Concurrent use with other topical agents containing alcohol or peroxide: may increase skin irritation.
• Application over extensive burns combined with systemic antibiotics: could mask signs of systemic infection.

Moderate Interactions (Monitor Closely)

• Use with topical corticosteroids: may reduce visible signs of infection, delaying assessment.
• Co‑administration with immunosuppressive agents: may impair wound healing.
• Combination with other topical antibiotics: monitor for additive irritation.
• Use with occlusive dressings: may increase local drug concentration and irritation risk.